The Pennant Group, Inc. (PNTG)
NASDAQ: PNTG · Real-Time Price · USD
29.73
+0.01 (0.03%)
Dec 15, 2025, 4:00 PM EST - Market closed
The Pennant Group Market Cap
The Pennant Group has a market cap or net worth of $1.03 billion as of December 15, 2025. Its market cap has decreased by -4.61% in one year.
Market Cap
1.03B
Enterprise Value
1.33B
1-Year Change
-4.61%
Ranking
Category
Stock Price
$29.73
Market Cap Chart
Since October 1, 2019, The Pennant Group's market cap has increased from $422.52M to $1.03B, an increase of 143.41%. That is a compound annual growth rate of 15.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 1.03B | 12.90% |
| Dec 31, 2024 | 910.92M | 118.67% |
| Dec 29, 2023 | 416.58M | 27.84% |
| Dec 30, 2022 | 325.85M | -50.42% |
| Dec 31, 2021 | 657.25M | -59.84% |
| Dec 31, 2020 | 1.64B | 77.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |